Previous 10 | Next 10 |
2024-04-29 10:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-24 10:00:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio meaningfully beat the benchmark MSCI EAFE Index, as well as the seconda...
2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...
2024-04-18 17:13:33 ET Related stories Grand Theft Auto publisher Take-Two Interactive to lay off 5% of workforce Equifax Earnings: Underwhelming Performance, Not Worth The Investment Tenet Healthcare: Shrinking To Grow Wabtec: Railing Along To Fresh Highs ...
2024-04-18 12:15:04 ET Wells Fargo analyst issues SECTOR PERFORM recommendation for ARGX on April 18, 2024 10:01AM ET. The previous analyst recommendation was Sector Perform. ARGX was trading at $363.76 at issue of the analyst recommendation. The overall analyst consensu...
ADHERE data show VYVGART ® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART ® treatment April 16, 2024...
2024-04-10 12:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...
2024-04-10 06:50:33 ET Summary Halozyme's ENHANZE technology drives growth, with Q4 2023 revenue up 27% YoY, projecting $915-$985 million in 2024. Key revenue from royalties, notably Darzalex Faspro, with a healthy financial state highlighted by a strong current ratio and stock re...
2024-04-04 02:12:07 ET Summary Immunovant's IMVT-1402 shows promise for at-home autoimmune treatment, with a differentiated subcutaneous delivery. Phase 1 data indicate significant IgG reductions without major side effects, advancing toward registrational trials. Financial hea...
2024-03-30 19:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
2024-06-26 07:00:04 ET Douglas Tsao from H.C. Wainwright issued a price target of $490.00 for ARGX on 2024-06-26 06:09:00. The adjusted price target was set to $490.00. At the time of the announcement, ARGX was trading at $451.55. The overall price target consensus is at...
ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of functional improvements with VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) , w...
2024-06-24 16:00:10 ET Joon Lee from Truist Financial issued a price target of $480.00 for ARGX on 2024-06-24 14:06:00. The adjusted price target was set to $480.00. At the time of the announcement, ARGX was trading at $441.155. The overall price target consensus is at $...